Skip to main content

Table 1 Laboratory data at the time of fistula formation in the two cases

From: Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report

 

Normal range

Patient 1

Patient 2

White blood cell (/μL)

Hemoglobin (g/dL)

Platelet (103/μL)

Total protein (g/dL)

Albumin (g/dL)

Fasting blood glucose (mg/dL)

HbA1c (%)

CRP (mg/dL)

TSH (mIU/L)

F-T4 (ng/dL)

Factor XIII (%)

BMI (kg/m2)

3300–8600

13.7–16.8

158–348

6.6–8.1

4.1–5.1

73–109

4.9–6.0

0.61–4.23

0.61–4.23

0.7–1.48

70–140

18.5–25

6630

10.0

357

6.1

3.2

75

5.1

1.8

6.57

1.02

100

16.5

7080

12.5

218

6.9

4.0

108

5.8

0.10

4.18

0.98

N.A

21.0

  1. *HbA1c glycated hemoglobin, CRP C-reactive protein, TSH thyroid-stimulating hormone, BMI body mass index [range according to the World Health Organization (WHO) Asian-BMI classification], N.A. not available